Astrazeneca (AZN) Pension (2009 - 2026)

Astrazeneca has reported Pension for 18 years, with the latest figure at -$852.0 million in Q2 2026.

• On a quarterly basis, Pension rose 39.92% year-over-year to -$852.0 million in Q2 2026; TTM through Jun 2026 was -$852.0 million, a 39.92% increase from a year earlier, with the FY2025 full-year figure at -$1.1 billion, up 16.92% from the prior year.
• Pension was -$852.0 million for Q2 2026 at Astrazeneca, up from -$953.0 million in the prior quarter.
• The five-year high for Pension was -$852.0 million in Q2 2026, with the low at -$2.0 billion in Q1 2022.
• Average Pension over 5 years is -$1.2 billion, with a median of -$1.3 billion recorded in 2025.
• The sharpest annual moves came in 2022 and 2023: Pension jumped 62.47% in 2022, then sank 30.14% in 2023.
• Over 5 years, Pension stood at -$1.2 billion in 2022, then tumbled by 30.14% to -$1.5 billion in 2023, then gained by 12.5% to -$1.3 billion in 2024, then increased by 16.92% to -$1.1 billion in 2025, then gained by 22.9% to -$852.0 million in 2026.
• The last three Pension figures came in at -$852.0 million (Q2 2026), -$953.0 million (Q1 2026), and -$1.1 billion (Q4 2025), per Business Quant data.